CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.12 / 10
Outperform
Analyst consensus is a single Strong Buy (100%) with 20% historic return, while fund‑flow score is 7.3/10, good. Small investors show strong inflow, though overall trend is negative. Sentiment score 7.12 supports a bullish outlook despite price decline.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-12
InstitutionMaxim Group
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of CNSP?
- CNSP holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.12/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
